Assessing the Literature for Optimal and Individualized Treatment


Tips to tailoring treatment of mood disorders using a measured approach.


From randomized trials, clinicians can take away a number of general principles to help guide the process of constructing a “profile” for optimal candidacy with one treatment relative to another. Joseph F. Goldberg, MD, provides tips to tailoring treatment of mood disorders using a measured approach.

Dr Goldberg is clinical professor of psychiatry, Icahn School of Medicine at Mount Sinai, New York. The author reports the following disclosures: Abbvie Pharmaceuticals: Speakers Bureau; American Psychiatric Publishing: Royalties; BioXCel: Consultant; Intra-cellular Therapies: Speakers Bureau; Neurocrine: Consultant; Otsuka: consultant; Sage Pharmaceuticals: Consultant; Sunovion: Consultant, Speakers Bureau. Dr Goldberg spoke at Psych Congress 2020 Virtual Experience in a presentation titled “Tailoring Individualized Pharmacotherapy for Bipolar Disorder: How to Translate Findings from Clinical Trials to a Single Patient.”

Related Videos
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.
© 2023 MJH Life Sciences

All rights reserved.